Φορτώνει......
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
Bruton’s tyrosine kinase (BTK) signaling is involved in innate immune responses and regulates the production of proinflammatory cytokines that can contribute to COVID-19 immunopathology. Clinical trials with BTK inhibitors in COVID-19 treatment have been proposed, and previous studies have attempted...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Leukoc Biol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361550/ https://ncbi.nlm.nih.gov/pubmed/32640487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/JLB.5COVR0620-306R |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|